Abstract
Small membrane proteins represent a largely unexplored yet abundant class of proteins in pro- and eukaryotes. They essentially consist of a single transmembrane domain and are associated with stress response mechanisms in bacteria. How these proteins are inserted into the bacterial membrane is unknown. Our study revealed that in Escherichia coli, the 27- amino-acid-long model protein YohP is recognized by the signal recognition particle (SRP), as indicated by in vivo and in vitro site-directed cross-linking. Cross-links to SRP were also observed for a second small membrane protein, the 33-amino-acid-long YkgR. However, in contrast to the canonical cotranslational recognition by SRP, SRP was found to bind to YohP posttranslationally. In vitro protein transport assays in the presence of a SecY inhibitor and proteoliposome studies demonstrated that SRP and its receptor FtsY are essential for the posttranslational membrane insertion of YohP by either the SecYEG translocon or by the YidC insertase. Furthermore, our data showed that the yohP mRNA localized preferentially and translation-independently to the bacterial membrane in vivo. In summary, our data revealed that YohP engages an unique SRP-dependent posttranslational insertion pathway that is likely preceded by an mRNA targeting step. This further highlights the enormous plasticity of bacterial protein transport machineries.
Original language | English |
---|---|
Article number | e3000874 |
Pages (from-to) | 1-33 |
Number of pages | 33 |
Journal | PloS Biology |
Volume | 18 |
Issue number | 9 |
DOIs | |
Publication status | Published - 30 Sept 2020 |
Funding
This work was supported by the German Science Foundation (grants SPP2002/KO2184/9-1; KO2184/8 and Project ID 235777276/GRK2202 to H-GK; Project ID 403222702/SFB 1381 to H-GK and CK; Project ID 259130777/SFB 1177, Project ID 409673687, and Project ID 390939984/CIBSSEXC- 2189 to CK), by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) (grant no. R15GM116032) to WQS, by the National Science Foundation LSAMP Program (grant no. HRD 1618408) to PMW and by an FF-Nord Fellowship to RS. SH is supported by a Welcome Trust Investigator Award in Science 204957/Z/16/Z. The Kraft laboratory has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement no. 769065, from the European Union's Horizon 2020 research and innovation program under grant agreement no. 765912, and from the EMBO Young Investigator Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funders | Funder number |
---|---|
European Union's Horizon 2020 research and innovation program | 765912, 769065 |
FF-Nord | |
German Science Foundation | SPP2002/KO2184/9-1, 259130777/SFB 1177, 409673687, 390939984/CIBSSEXC- 2189, 235777276/GRK2202, KO2184/8, 403222702/SFB 1381 |
Welcome Trust | 204957/Z/16/Z |
National Science Foundation | HRD 1618408 |
National Institutes of Health | |
National Institute of General Medical Sciences | R15GM116032 |
European Research Council | |
EMBO |